SCHEMBL21048499

SCHEMBL21048499

CN(C)c1ccc(C2C(=O)c3cccnc3C2=O)cc1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 0.42
KMT2A Q03164 5/20 0.42
MEN1 O00255 4/20 0.42
NPC1 O15118 4/20 0.42
RAB9A P51151 4/20 0.42
TP53 P04637 3/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
MAPK10 P53779 1/20 0.42
APP P05067 2/20 0.41
SNCA P37840 2/20 0.41
GAA P10253 2/20 0.40
HPGD P15428 1/20 0.40
MAOA P21397 1/20 0.40
PTGS2 P35354 1/20 0.40
TDP2 O95551 1/20 0.40
NSD2 O96028 1/20 0.40
ABL1 P00519 1/20 0.40
PLCG1 P19174 1/20 0.40
CES1 P23141 1/20 0.40
PAX8 Q06710 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21048546 0.81 MAPT (0.62) MAPTKMT2AMEN1NPC1RAB9A
SCHEMBL14940277 0.73 KMT2A (0.42) MAPTKMT2AMEN1NPC1RAB9A
SCHEMBL9545532 0.66 MAPT (0.35) MAPTKMT2AMEN1APPSNCA
SCHEMBL7721595 0.66 PADI1 (0.50) MAPTKMT2AMEN1APPSNCA
SCHEMBL7721587 0.66 S100A4 (0.50) MAPTKMT2AMEN1SMN1; SMN2APP
SCHEMBL12520643 0.65 MAPT (0.46) MAPTTP53SMN1; SMN2GAATDP1
SCHEMBL1314052 0.63 S100A4 (0.49) MAPTKMT2AMEN1NPC1RAB9A
SCHEMBL27963289 0.63 PARP1 (0.50) MAPTNPC1RAB9ATP53SMN1; SMN2
SCHEMBL14939510 0.62 KMT2A (0.59) MAPTKMT2AMEN1NPC1RAB9A
SCHEMBL12520896 0.62 MAPT (0.46) MAPTKMT2AMEN1NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3611158-B1 1,3-DI-OXO-INDENE DERIVATIVE, PHARMACEUTICALLY ACCEPTABLE SALT OR OPTICAL ISOMER THEREOF, PREPARATION METHOD THEREOF, AND PHARMACEUTICAL COMPOSITION CONTAINING SAME AS AN ANTIVIRAL, ACTIVE INGREDIENT KOREA RES INST CHEMICAL TECH (KR) 2023-12-20 EP disclosed
EP-2722322-B1 1,3-DI-OXO-INDENE DERIVATIVE, PHARMACEUTICALLY ACCEPTABLE SALT OR OPTICAL ISOMER THEREOF, PREPARATION METHOD THEREOF, AND PHARMACEUTICAL COMPOSITION CONTAINING SAME AS AN ANTIVIRAL, ACTIVE INGREDIENT KOREA RES INST CHEMICAL TECH (KR) 2019-06-12 EP disclosed